Document is current
Any future updates will be listed below
-
Authors
Sveen, Anita
Bergsland, Christian H.
Niederdorfer, Barbara
Berstad, Audun E.
Bjerkehagen, Bodil
Boye, Kjetil
Guren, Tormod K.
Lothe, Ragnhild A.
-
Funding
Funding for this research was provided by:
Radiumhospitalets legater
Helse Sør-Øst RHF (2020064)
- License Information
-
More Information
Article History
Received: 2 July 2025
Accepted: 19 January 2026
First Online: 27 February 2026
Competing interests
: K.B. has received consulting fees from Bayer, GSK, Incyte, Blueprint Medicines, and NEC Oncoimmunity, and honoraria for presentations or educational events from Deciphera Pharmaceuticals, Boehringer Ingelheim, and Novartis. T.K.G. reports support to the Institution from Pierre Fabre, Bayer, Incyte, Merck Serono, and Daiichi Sankyo outside the submitted work. The other authors report no competing interests.
